Literature DB >> 8172858

Stimulation of PAI-1 expression in endothelial cells by cultured vascular smooth muscle cells.

M Gallicchio1, S Argyriou, G Ianches, E L Filonzi, H Zoellner, J A Hamilton, K McGrath, J Wojta.   

Abstract

Regulation of endothelial cell (EC) plasminogen activator inhibitor type-1 (PAI-1), the primary physiological inhibitor of tissue-type plasminogen activator (TPA) and urokinase-type plasminogen activator (UPA), by various stimuli has been well characterized. We report the upregulation of secreted and intracellular PAI-1 in human umbilical ECs when cocultured with human smooth muscle cells (SMCs) on amniotic membranes or incubated with SMC conditioned medium (CM) under serum-free conditions as determined by enzyme-linked immunosorbent assay. Cocultured human umbilical vein ECs and SMCs, or human umbilical artery ECs and SMCs, displayed a 73% and 68% increase, respectively, in released PAI-1. SMC-derived stimulatory factor release showed tissue specificity, since only human aortic, umbilical vein, and umbilical artery SMCs upregulated PAI-1 synthesis, whereas SMCs from human mammary artery, pulmonary artery, and saphenous vein did not. Stimulation of EC PAI-1 by SMC CM was both time and concentration dependent, with as much as five- and fourfold increases in supernatants and lysates, respectively. PAI-1 synthesis and activity in ECs from other vascular beds were also upregulated by SMC CM. Northern blot analysis paralleled the protein results, showing as much as a 2.7-fold increase in specific EC PAI-1 mRNA expression after incubation with SMC CM for 8 hours. PAI-1 stimulatory activity in SMC CM was completely abolished by boiling or incubation with protamine sulfate and was reduced by transient acidification or heparin-Sepharose pretreatment by 33% or 48%, respectively. The stimulatory factor(s) appeared to have a molecular mass of 23 kD as determined by gel filtration.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8172858     DOI: 10.1161/01.atv.14.5.815

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  5 in total

1.  Ability of various inserts to promote endothelium cell culture for the establishment of coculture models.

Authors:  F Villars; V Conrad; F Rouais; F Lefebvre; J Amédée; L Bordenave
Journal:  Cell Biol Toxicol       Date:  1996-12       Impact factor: 6.691

2.  Effects of plasminogen activator inhibitor-1-specific RNA aptamers on cell adhesion, motility, and tube formation.

Authors:  Stephanie Brandal; Charlene M Blake; Bruce A Sullenger; Yolanda M Fortenberry
Journal:  Nucleic Acid Ther       Date:  2011-11-21       Impact factor: 5.486

3.  Drug packaging and delivery using perfluorocarbon nanoparticles for targeted inhibition of vascular smooth muscle cells.

Authors:  Zhao-xiong Zhou; Bai-gen Zhang; Hao Zhang; Xiao-zhong Huang; Ya-li Hu; Li Sun; Xiao-min Wang; Ji-wei Zhang
Journal:  Acta Pharmacol Sin       Date:  2009-11       Impact factor: 6.150

Review 4.  Systemic versus localized coagulation activation contributing to organ failure in critically ill patients.

Authors:  Marcel Levi; Tom van der Poll; Marcus Schultz
Journal:  Semin Immunopathol       Date:  2011-07-30       Impact factor: 9.623

Review 5.  Endothelial heterogeneity in the umbilico-placental unit: DNA methylation as an innuendo of epigenetic diversity.

Authors:  Paola Casanello; Daniela Schneider; Emilio A Herrera; Ricardo Uauy; Bernardo J Krause
Journal:  Front Pharmacol       Date:  2014-03-27       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.